Loading clinical trials...
Loading clinical trials...
The aim of this study is to correlate the phenotype and genotype among a sample of Egyptian patients with Congenital myopathies and Congenital muscular dystrophies.
Congenital Muscular dystrophies (CMDs) and Congenital Myopathies (CMs) constitute the two most important groups of congenital muscle diseases with early onset whether at birth or early infancy. CMDs and CMs as a group encompass great clinical and genetic heterogeneity so that achieving an accurate genetic diagnosis has become increasingly challenging, even in the era of next generation sequencing. However, it has become clear that there is overlap between CMDs and CMs on the clinical, pathological and genetic level.
Age
1 - 18 years
Sex
ALL
Healthy Volunteers
Yes
Ain Shams University
Cairo, Egypt
Start Date
June 30, 2024
Primary Completion Date
June 30, 2026
Completion Date
June 30, 2026
Last Updated
August 24, 2025
25
ESTIMATED participants
Genetic Testing and Muscle Biopsy
DIAGNOSTIC_TEST
Lead Sponsor
Ain Shams University
NCT04065399
NCT06561048
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions